TDB
ABBV icon

Thompson David Blair’s AbbVie ABBV Stock Holding History

Thompson David Blair’s Portfolio ABBV Stock Details ABBV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$571K Buy
2,271
+53
+2% +$11.4K 0.29% 113
2026
Q1 		$482K Sell
2,218
-346
-13% -$76.8K 0.28% 101
2025
Q4 		$586K Buy
+2,564
New +$584K 0.33% 81

Other funds holding ABBV

BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
JP Morgan Chase
JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Capital Research Global Investors
Capital Research Global Investors Los Angeles, California $717B AUM 35.42% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $1T AUM
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

Thompson David Blair's ABBV Position: Q2 2026 in Review

Thompson David Blair increased its AbbVie (ABBV) stake by 2.4% in Q2 2026, buying an estimated $11.4K and bringing the position to 2,271 shares worth $571K. The position accounts for 0.29% of the portfolio, ranked #113.

Thompson David Blair first reported a position in ABBV in Q4 2025 and has held it in 3 quarters since. The position peaked at $586K in Q4 2025. 4,063 funds tracked by Wall St. Rank hold ABBV as of Q2 2026.

  • Thompson David Blair held 2,271 shares of AbbVie worth $571K as of Q2 2026.
  • Thompson David Blair bought 53 AbbVie shares in Q2 2026, an estimated $11.4K.
  • AbbVie made up 0.29% of Thompson David Blair's portfolio in Q2 2026, its #113 holding.
  • Thompson David Blair first reported a position in AbbVie in Q4 2025 and has held it in 3 quarters since.
  • Thompson David Blair's AbbVie position peaked at $586K in Q4 2025.
  • 4,063 funds tracked by Wall St. Rank held AbbVie as of Q2 2026.

Based on Thompson David Blair's 13F filing for Q2 2026, filed 14 Aug 2026.